| Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 |
|---|---|---|---|---|---|---|---|---|
Continuing Operations [Member] | ||||||||
Discontinued Operations [Member] | ||||||||
Sales (note 22) | ||||||||
174,346 | 72,431 | 67,414 | 62,932 | 71,774 | 49,216 | 56,842 | 33,401 | - |
Sales (note 22) | ||||||||
- | - | - | - | - | - | - | - | 84,197 |
Cost of sales | ||||||||
20,240 | 22,393 | 18,408 | 15,476 | 20,505 | 19,100 | 21,128 | 16,718 | 20,063 |
Gross profit | ||||||||
154,106 | 50,038 | 49,006 | 47,456 | 51,269 | 30,116 | 35,714 | 16,682 | 64,133 |
Selling, general and administrative expenses (including rent expenses incurred to related party of 2017 - $793, 2016 - $807, 2015 - $852) (note 11(b)) | ||||||||
87,365 | 41,980 | 37,481 | 34,338 | 33,611 | 33,280 | 23,809 | 18,885 | 18,165 |
Provision (recovery) for doubtful accounts | ||||||||
934 | 1,412 | -49 | 329 | -504 | -874 | -167 | 1,921 | - |
Provision for doubtful accounts | ||||||||
- | - | - | - | - | - | - | - | 17 |
Research and development expenses | ||||||||
20,489 | 12,648 | 9,490 | 10,934 | 8,128 | 17,044 | 9,007 | 8,507 | 4,405 |
Loss on disposal of property, plant and equipment (note 8) | ||||||||
-42 | -478 | -26 | - | - | - | - | - | -169 |
Depreciation of property, plant and equipment and amortization of licenses | ||||||||
- | - | - | - | - | - | - | 1,411 | 692 |
Loss on disposal and impairment of property, plant and equipment (note 9) | ||||||||
- | - | - | -74 | -88 | -2,190 | -455 | -1,237 | - |
Government grants recognized in income | ||||||||
141 | 6,984 | 1,637 | 104 | 0 | 373 | 764 | 1,924 | 1,295 |
Total operating expenses | ||||||||
108,689 | 49,534 | 45,311 | 45,571 | 41,323 | 51,267 | 32,340 | 30,039 | 21,985 |
Operating income | ||||||||
45,417 | 504 | 3,695 | 1,885 | 9,946 | -21,151 | 3,374 | -13,356 | 42,148 |
Interest and financing expenses - (including interest expenses incurred to related party, 2017 - $262, 2016 - $176, 2015 - $183) (note 11(a)) | ||||||||
1,569 | 1,729 | 1,920 | 3,407 | 3,031 | 775 | 384 | 1,178 | 534 |
Interest income | ||||||||
1,183 | 731 | 1,155 | 2,684 | 2,167 | 2,370 | 1,397 | 1,132 | 143 |
Other income (expenses), net | ||||||||
13 | 100 | -174 | 1,186 | - | - | - | - | - |
Other income | ||||||||
- | - | - | - | 329 | -77 | 280 | 95 | -33 |
Income (loss) from continuing operations before income taxes | ||||||||
45,044 | -394 | 2,756 | 2,348 | 9,411 | -19,633 | 4,667 | -13,305 | - |
Income (loss) before income taxes and non-controlling interests | ||||||||
- | - | - | - | - | - | - | - | 41,553 |
Income tax expense (note 13) | ||||||||
8,339 | 2,664 | 2,985 | 2,069 | -2,225 | -884 | 5,066 | -703 | 11,140 |
Income (loss) from continuing operations | ||||||||
36,705 | -3,058 | -229 | 279 | 11,636 | - | - | - | - |
Income (loss) from discontinued operations, net of tax of nil (note 3) | ||||||||
0 | 2,338 | -728 | -1,524 | -1,266 | - | - | - | - |
Net income (loss) | ||||||||
36,705 | -720 | -957 | -1,245 | 10,370 | -18,749 | -399 | -12,602 | 30,413 |
Less: (Income) loss attributable to non-controlling interests | ||||||||
10,898 | -124 | 459 | 270 | 2,928 | -3,896 | 445 | -4,094 | -10,454 |
Net income (loss) attributable to shareholders of Sinovac | ||||||||
25,807 | -596 | -1,416 | -1,515 | 7,442 | -14,853 | -844 | -8,507 | 19,958 |
Income (loss) from continuing operations | ||||||||
36,705 | -3,058 | -229 | 279 | 11,636 | - | - | - | - |
Net loss | ||||||||
36,705 | -720 | -957 | -1,245 | - | - | - | -12,602 | 30,413 |
Foreign currency translation adjustments | ||||||||
- | - | - | -2,320 | - | 2,024 | 3,639 | 3,547 | - |
Income (loss) from discontinued operations | ||||||||
0 | 2,338 | -728 | -1,524 | -1,266 | - | - | - | - |
Comprehensive income (loss) | ||||||||
44,803 | -9,563 | -5,342 | -3,648 | 13,056 | -16,725 | 3,240 | -9,054 | - |
Foreign currency translation adjustment | ||||||||
- | - | - | - | - | - | - | - | 99 |
Total comprehensive income (loss) | ||||||||
- | - | - | - | - | - | - | - | 30,512 |
Less: comprehensive (income) loss attributable to non-controlling interests | ||||||||
12,089 | -953 | -82 | -35 | 3,244 | -3,665 | 973 | -3,205 | 10,472 |
Comprehensive income (loss) attributable to shareholders of Sinovac | ||||||||
32,714 | -8,610 | -5,260 | -3,613 | 9,812 | -13,060 | 2,267 | -5,848 | 20,040 |
Other comprehensive income (loss) from discontinued operations, net of tax of nil | ||||||||
Earnings (loss) per share (note 22) | ||||||||
Basic net income (loss) per share: | ||||||||
Continuing operations | ||||||||
0.45 | -0.05 | -0.02 | 0.00 | 0.15 | - | - | - | - |
Discontinued operations | ||||||||
0.00 | 0.04 | -0.01 | -0.03 | -0.02 | - | - | - | - |
Basic net income (loss) per share | ||||||||
0.45 | -0.01 | -0.03 | -0.03 | 0.13 | - | - | - | 0.47 |
Diluted net income (loss) per share: | ||||||||
Continuing operations | ||||||||
0.45 | -0.05 | -0.02 | 0.00 | 0.15 | - | - | - | - |
Discontinued operations | ||||||||
0.00 | 0.04 | -0.01 | -0.03 | -0.02 | - | - | - | - |
Diluted net income (loss) per share | ||||||||
0.45 | -0.01 | -0.03 | -0.03 | 0.13 | - | - | - | 0.46 |
Basic and diluted earnings(loss) per share (note 20) (in dollars per share) | ||||||||
- | - | - | - | - | -0.27 | -0.02 | -0.16 | - |
Weighted average number of shares of common stock outstanding | ||||||||
- Basic | ||||||||
57,033 | 56,949 | 56,313 | 55,681 | 55,301 | 54,926 | 54,608 | - | 42,580 |
- Diluted | ||||||||
57,101 | 56,949 | 56,313 | 56,114 | 55,802 | 54,926 | 54,608 | - | 42,975 |
Basic and Diluted (in shares) | ||||||||
- | - | - | - | - | - | - | 53,064 | - |